EGFR and neoplasm: Apicella et al. revealed that the metabolic shift in tumor cells induced by tyrosine kinase inhibitors (TKIs) targeting mesenchymal-epithelial transition factor or epidermal growth factor receptor (EGFR), which results in increased lactate production, prompts CAFs to excessively produce HGF.